Induced pluripotent stem cells in the study of neurological diseases

Mario da Cunha Saporta, Marica Grskovic, John T. Dimos

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Five years after their initial derivation from mouse somatic cells, induced pluripotent stem (iPS) cells are an important tool for the study of neurological diseases. By offering an unlimited source of patientspecific disease-relevant neuronal and glial cells, iPS cell-based disease models hold enormous promise for identification of disease mechanisms, discovery of molecular targets and development of phenotypic screens for drug discovery. The present review focuses on the recent advancements in modeling neurological disorders, including the demonstration of diseasespecific phenotypes in iPS cell-derived neurons generated from patients with spinal muscular atrophy, familial dysautonomia, Rett syndrome, schizophrenia and Parkinson disease. The ability of this approach to detect treatment effects from known therapeutic compounds has also been demonstrated, providing proof of principle for the use of iPS cell-derived cells in drug discovery.

Original languageEnglish (US)
Article number37
JournalStem Cell Research and Therapy
Volume2
Issue number5
DOIs
StatePublished - Sep 21 2011
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Drug Discovery
Familial Dysautonomia
Rett Syndrome
Spinal Muscular Atrophy
Aptitude
Therapeutic Uses
Nervous System Diseases
Neuroglia
Parkinson Disease
Schizophrenia
Neurons
Identification (control systems)
Phenotype
Demonstrations
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Cell Biology

Cite this

Induced pluripotent stem cells in the study of neurological diseases. / da Cunha Saporta, Mario; Grskovic, Marica; Dimos, John T.

In: Stem Cell Research and Therapy, Vol. 2, No. 5, 37, 21.09.2011.

Research output: Contribution to journalArticle

@article{af9d8d9528944a038c63c0827986878d,
title = "Induced pluripotent stem cells in the study of neurological diseases",
abstract = "Five years after their initial derivation from mouse somatic cells, induced pluripotent stem (iPS) cells are an important tool for the study of neurological diseases. By offering an unlimited source of patientspecific disease-relevant neuronal and glial cells, iPS cell-based disease models hold enormous promise for identification of disease mechanisms, discovery of molecular targets and development of phenotypic screens for drug discovery. The present review focuses on the recent advancements in modeling neurological disorders, including the demonstration of diseasespecific phenotypes in iPS cell-derived neurons generated from patients with spinal muscular atrophy, familial dysautonomia, Rett syndrome, schizophrenia and Parkinson disease. The ability of this approach to detect treatment effects from known therapeutic compounds has also been demonstrated, providing proof of principle for the use of iPS cell-derived cells in drug discovery.",
author = "{da Cunha Saporta}, Mario and Marica Grskovic and Dimos, {John T.}",
year = "2011",
month = "9",
day = "21",
doi = "10.1186/scrt78",
language = "English (US)",
volume = "2",
journal = "Stem Cell Research and Therapy",
issn = "1757-6512",
publisher = "BioMed Central",
number = "5",

}

TY - JOUR

T1 - Induced pluripotent stem cells in the study of neurological diseases

AU - da Cunha Saporta, Mario

AU - Grskovic, Marica

AU - Dimos, John T.

PY - 2011/9/21

Y1 - 2011/9/21

N2 - Five years after their initial derivation from mouse somatic cells, induced pluripotent stem (iPS) cells are an important tool for the study of neurological diseases. By offering an unlimited source of patientspecific disease-relevant neuronal and glial cells, iPS cell-based disease models hold enormous promise for identification of disease mechanisms, discovery of molecular targets and development of phenotypic screens for drug discovery. The present review focuses on the recent advancements in modeling neurological disorders, including the demonstration of diseasespecific phenotypes in iPS cell-derived neurons generated from patients with spinal muscular atrophy, familial dysautonomia, Rett syndrome, schizophrenia and Parkinson disease. The ability of this approach to detect treatment effects from known therapeutic compounds has also been demonstrated, providing proof of principle for the use of iPS cell-derived cells in drug discovery.

AB - Five years after their initial derivation from mouse somatic cells, induced pluripotent stem (iPS) cells are an important tool for the study of neurological diseases. By offering an unlimited source of patientspecific disease-relevant neuronal and glial cells, iPS cell-based disease models hold enormous promise for identification of disease mechanisms, discovery of molecular targets and development of phenotypic screens for drug discovery. The present review focuses on the recent advancements in modeling neurological disorders, including the demonstration of diseasespecific phenotypes in iPS cell-derived neurons generated from patients with spinal muscular atrophy, familial dysautonomia, Rett syndrome, schizophrenia and Parkinson disease. The ability of this approach to detect treatment effects from known therapeutic compounds has also been demonstrated, providing proof of principle for the use of iPS cell-derived cells in drug discovery.

UR - http://www.scopus.com/inward/record.url?scp=84863360741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863360741&partnerID=8YFLogxK

U2 - 10.1186/scrt78

DO - 10.1186/scrt78

M3 - Article

C2 - 21936964

AN - SCOPUS:84863360741

VL - 2

JO - Stem Cell Research and Therapy

JF - Stem Cell Research and Therapy

SN - 1757-6512

IS - 5

M1 - 37

ER -